Navigation Links
Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
Date:12/6/2012

nd is being developed for the treatment of cognitive disorders, including schizophrenia where OMS824 could also have a beneficial effect on the positive (e.g., hallucinations) and negative (e.g., flat affect) symptoms of the disease.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-Looking Statements
This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, Omeros' expectations regarding when it will announce the remaining data from its Phase 1 clinical trial evaluating OMS824; that it will announce Phase 3 data from its OMS103HP program this month; that it will submit an NDA next quarter for OMS302; that as many as three additional programs will enter the clinic in 2013; and that Omeros may have capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information availa
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference
2. Omeros is Not Aware of Any Justification for Share Price Movement
3. Omeros Corporation Reports Third Quarter 2012 Financial Results
4. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
5. Omeros Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial
6. Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
7. Omeros to Present at Two Upcoming Conferences
8. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Discovery in MASP-2 Program
11. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Texas, premier physician associations ... doctors the survival tools they need to provide demonstrably ... today,s health care marketplace. "I am confident ... local practices," said Stephen L. Brotherton ... " Texas doctors are determined to ...
(Date:5/23/2013)... 2013   Direct to implant, or "one ... appropriate option for many women with BRCA (BReast ... breast cancer risk, or with breast cancer. Traditionally, ... a second surgery to insert permanent implants, but ... as mastectomy can be a medically and cosmetically ...
(Date:5/23/2013)... May 23, 2013  BioElectronics Corporation (OTC Pink: BIEL), ... comments on the FDA panel meeting for non-thermal shortwave ... – Pulsed Shortwave Therapy Meeting was held on May ... USA.  The focus of the meeting was very narrow, ... focus solely on the application of non-thermal shortwave diathermy ...
Breaking Medicine Technology:TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2
... 2 STAAR Surgical Company (Nasdaq: STAA ), ... ophthalmic products, today reported that it generated $464,000 in ... The cash generated was the largest amount from operating ... years. This achievement was made possible due ...
... , HOPKINTON, Mass., Nov. 2 Caliper Life Sciences, Inc. ... tools, presented at a training session for reviewers from the ... of the LabChip GX platform for high throughput screening and ... accept the FDA,s invitation to present our LabChip platform to ...
Cached Medicine Technology:STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 2STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 3STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 4STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 5STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 6STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 7STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 8STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 9STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 10STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 11STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 12STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 13STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 14STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 15STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 16STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 17STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 18STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 19STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 20STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 21STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 22STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 23STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter 24Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration 2
(Date:5/24/2013)... Bridal Buy , a leading wedding dress online ... dresses are available in its wedding dresses 2013 ... fine fabrics, elegant beading, and exquisite embroidery. , ... eye for detailed designs. However, our lace spring wedding ... patterns and the hands of dressmakers,” said, Donnie Terry, ...
(Date:5/24/2013)... 2013 Psoriasis treatment cream has been ... This new FDA registered company is now offering its ... appearance of Psoriasis infected skin. , Dermasis has launched ... online. This soothing cream is designed to offer immediate ... and appearance of red skin often caused by psoriasis ...
(Date:5/23/2013)... blood glucose is associated with poor outcomes in hospitalized ... control hyperglycemia is a common practice in hospitals. But ... and even shows harms associated with the use of ... Clinical Guidelines Committee in a new evidence-based paper published ... Quality . , "Clinicians caring for hospitalized patients must ...
(Date:5/23/2013)... 24, 2013 On March 14, 2012, Kim ... will hear in her lifetime: she had breast cancer. Her ... After a Breast Cancer Diagnosis ” (published by AuthorHouse), takes ... Rideout drew from her daily journals to give readers a ... chemotherapy and radiation treatments to deal with stage two breast ...
(Date:5/23/2013)... May 23, 2013 If you are ... irritable bowel syndrome (IBS), the food spread this Memorial ... fun. , “While hot dogs and ice cream have ... warm weather months, IBS sufferers often feel the painful ... MD, a gastroenterologist with Lourdes Medical Associates. , IBS ...
Breaking Medicine News(10 mins):Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Kimberley Rideout Shares Her Triumphant Cancer Survival Story 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3
... VSCP ), a leading provider of quantitative ... the company,s chief executive,officer, will be presenting a corporate ... Conference at the Waldorf Astoria in New York City. ... at 3:45pm EST. , A ...
... finds all breaks, not just hip fractures, tied to increased ... fracture that occurs in people over age 60 needs to ... the Australian researchers found the risk of dying goes up ... for at least 10 years after a hip fracture. , ...
... former Senator Tom Daschle withdrew his name for consideration ... Human Services Department (HHS). From the beginning Senator ... for President Obama for a government takeover of our ... record while in the Senate, Family Research Council has ...
... Nearly three out of four Americans (71 ... cost of addiction treatment - yet most consumers ... would pay for substance abuse treatment, according to ... Hazelden, the national nonprofit organization that helps people ...
... until third year, study finds , , TUESDAY, Feb. ... period" for hormone replacement therapy has been identified ... that using estrogen-plus-progesterone therapy increases the risk for ... than taking estrogen alone. , The finding follows ...
... One-fifth of women who should receive radiation after a ... to a new study from researchers at the University ... at 396 women who were treated with a mastectomy ... of women who fell clearly within guidelines recommending radiation ...
Cached Medicine News:Health News:VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference 2Health News:Fractures in Older Adults Up Death Risk 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 3Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 4Health News:2 Years of Hormone Use May Be 'Safe' 2Health News:19 percent of breast cancer patients don’t receive recommended radiation after mastectomy 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: